BGC vs CME vs VRSK Stock Comparison

Bgc, Cme and Verisk Analytics Prices as of Nov 13, 2026 Peers: Industry group
BGC BGC Group, Inc.
$11.10 -3.6% 1M +22.4% 1Y
Market cap
$5.25B
P/E
22.5x
Revenue (TTM)
$3.39B
Div. yield
0.01%
Institutional Trading Financial Services
6 wins
CME Cme Group Inc.
$317.97 +11.3% 1M +12.1% 1Y
Market cap
$114.18B
P/E
25.9x
Revenue (TTM)
$6.97B
Div. yield
–
Exchanges Financial Services
4 wins
VRSK Verisk Analytics, Inc.
$207.82 +15.1% 1M -4.5% 1Y
Market cap
$27.51B
P/E
31.3x
Revenue (TTM)
$3.18B
Div. yield
–
Financial Data and Analytics Financial Services
1 win

Head to Head

11 decided of 12

Bgc leads on 6 of the 12 questions below (Bgc 6, Cme 4, Verisk Analytics 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBGCCMEVRSKLeader
Larger companyMarket capitalisation $5.25B $114.18B $27.51B CME
Cheaper on earningsLower P/E, profitable companies only 22.5x 25.9x 31.3x BGC
Cheaper on forward earningsLower price / next fiscal year consensus EPS 7.9x 27.1x 26.1x BGC
Faster revenue growthRevenue growth, trailing twelve months +22.9% +9.0% +4.9% BGC
More profitableNet margin, trailing twelve months 6.9% 63.3% 27.7% CME
Better return on capitalReturn on invested capital 10.6% 11.7% 31.9% VRSK
Less leveragedLower net debt / EBITDA 1.8x 0.2x 2.3x CME
Higher dividend yieldTrailing dividend yield 0.01% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +22.4% +12.1% -4.5% BGC
Better 5-year returnAnnualised price return, 5 years +17.3%/yr +7.2%/yr -0.8%/yr BGC
Less volatileAnnualised volatility, 1 year 34.5% 25.5% 36.4% CME
Higher overall scoreMean of the five percentile scores vs peers 66/100 63/100 54/100 BGC

Percentile Scorecard

BGCCMEVRSK

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBGCCMEVRSK
Valuation 92 #12 of 134 53 #63 of 134 37 #699 of 1108
Growth 75 #22 of 84 30 #59 of 84 40 #540 of 897
Profitability 49 #45 of 88 87 #12 of 88 95 #46 of 922
Financial Health 37 #96 of 151 51 #75 of 151 27 #798 of 1098
Shareholder Returns 75 #13 of 49 92 #5 of 49 70 #230 of 758
Overall 66 63 54
  • BGC ranked among 158 companies in Capital Markets
  • CME ranked among 158 companies in Capital Markets
  • VRSK ranked among 1,197 companies in Financial Services

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBGCCMEVRSKSPY
1 month -3.6%+11.3%+15.1% -2.0%
3 months -0.9%+17.9%+14.4% -2.8%
6 months -0.8%+6.4%+27.8% +2.0%
Year to date +24.3%+16.4%-7.1% +10.6%
1 year +22.4%+12.1%-4.5% +12.2%
3 years +74.8%+50.2%-12.7% +68.1%
3 years, per year +20.5%+14.5%-4.4% +18.9%
5 years +122.0%+41.4%-3.9% +61.4%
5 years, per year +17.3%+7.2%-0.8% +10.1%
10 years +82.6%+178.0%+150.0% +248.5%
10 years, per year +6.2%+10.8%+9.6% +13.3%

Risk

MeasureBGCCMEVRSKSPY
Volatility, 1Y 34.5%25.5%36.4% 13.6%
Downside volatility, 1Y 34.4%27.2%36.8% 13.9%
Beta vs S&P 500, 1Y 0.54-0.30-0.58 1.00
Return / volatility, 1Y 0.650.48-0.12 0.90
Max drawdown, 5Y -37.1%-33.1%-51.2% -25.4%
From 52-week high -12.3%-2.6%-7.7% -3.2%
52-week high $12.65$326.46$225.07 $779.14
52-week low $8.31$218.58$156.84 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBGCCMEVRSK
P/E now vs peer median 22.5xmedian 42.3x 25.8xmedian 42.3x 30.5xmedian 14.9x
P/S now vs peer median 1.5xmedian 3.9x 16.3xmedian 3.9x 8.4xmedian 3.2x
EV/EBITDA now vs peer median 11.5xmedian 12.7x 23.4xmedian 12.7x 17.5xmedian 6.3x
P/FCF now vs peer median 9.5xmedian 16.5x 26.2xmedian 16.5x 24.2xmedian 10.5x
P/B now vs peer median 4.2xmedian 3.7x 4.3xmedian 3.7x -23.9xmedian 1.3x
PEG now vs peer median 0.19median 0.52 1.88median 0.52 1.20median 0.89

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBGCCMEVRSK
Revenue $3.39B $6.97B $3.18B
Gross profit – $1.37B $2.23B
Operating income – $4.58B $1.39B
Net income $242.30M $4.42B $879.20M
Free cash flow $552.65M $4.33B $1.10B
EPS (diluted) $0.49 $12.31 $6.80
Cash & equivalents $822.06M $2.20B $556.80M
Total debt $1.78B $3.43B $4.50B
Shares (diluted) 476.33M 358.64M 129.23M
Enterprise value $2.03B $102.52B $23.69B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBGCCMEVRSK
P/E 22.5x 25.8x 30.5x
P/FCF 9.5x 26.2x 24.2x
P/Operating cash flow 8.7x 25.7x 19.5x
P/S 1.5x 16.3x 8.4x
P/B 4.2x 4.3x -23.9x
P/Tangible book 6.1x 4.7x -18.8x
EV/EBITDA 11.5x 23.4x 17.5x
EV/EBIT 13.2x 25.1x 21.9x
EV/Revenue 1.8x 16.5x 9.6x
EV/FCF 11.2x 26.5x 27.8x
EV/Operating cash flow 10.3x 25.9x 22.4x
PEG (3Y EPS CAGR) 0.19 1.88 1.20

Growth

14 metrics
MetricBGCCMEVRSK
Revenue growth (1Y) 22.9% 9.0% 4.9%
Revenue CAGR (3Y) 20.3% 9.2% 6.4%
Gross profit growth (1Y) – 13.2% 5.7%
Gross profit CAGR (3Y) – 12.5% 7.8%
Operating income growth (1Y) – 10.1% 3.6%
Operating income CAGR (3Y) – 12.2% 6.2%
Net income growth (1Y) 49.5% 17.3% -4.6%
Net income CAGR (3Y) 125.6% 13.1% 20.6%
EPS growth (1Y) 47.1% 19.4% 3.3%
EPS CAGR (3Y) 115.9% 13.7% 25.5%
Operating cash flow growth (1Y) 29.2% 6.4% 1.4%
Operating cash flow CAGR (3Y) 22.9% 9.3% 8.9%
Free cash flow growth (1Y) 24.9% 6.1% -1.4%
Free cash flow CAGR (3Y) 21.2% 9.4% 11.0%

Profitability

14 metrics
MetricBGCCMEVRSK
Gross margin – 19.7% 70.2%
EBITDA margin 15.9% 70.4% 55.0%
Operating margin – 65.7% 43.9%
Pretax margin 10.0% 82.8% 36.3%
Net margin 6.9% 63.3% 27.7%
FCF margin 16.3% 62.1% 34.6%
Operating cash flow margin 17.8% 63.5% 43.0%
Return on equity 18.4% 16.6% –
Return on assets 4.1% 2.3% 19.5%
Return on invested capital 10.6% 11.7% 31.9%
Return on capital employed – 12.3% 40.5%
Asset turnover 0.6x 0.0x 0.7x
Cash conversion (OCF / net income) 2.5x 1.0x 1.6x
Stock comp / revenue 9.7% 1.4% 1.9%

Financial Health

11 metrics
MetricBGCCMEVRSK
Debt / assets 30.8% 1.8% 99.0%
Debt / equity 1.4x 0.1x -4.0x
Net debt / EBITDA 1.8x 0.2x 2.3x
Debt / FCF 3.2x 0.8x 4.1x
Liabilities / assets 78.2% 86.2% 124.5%
Equity / assets 21.8% 13.8% -24.5%
Interest coverage 3.6x 26.2x 6.8x
Current ratio – 1.0x 1.1x
Quick ratio – 0.0x 0.9x
Cash ratio – 0.0x 0.5x
Altman Z-score – 0.59 7.12

Shareholder Returns

7 metrics
MetricBGCCMEVRSK
Dividend yield 0.7% 3.1% 0.9%
Net buyback yield 5.8% – 7.0%
Shareholder yield 6.5% 3.1% 7.9%
Payout ratio (earnings) 15.9% – –
Payout ratio (FCF) 7.0% – –
Dividend growth (1Y) -1.3% – –
Dividend CAGR (3Y) 34.1% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBGCCMEVRSK
Forward P/E 7.9xFY2026 27.1xFY2026 26.1xFY2026
EPS, next fiscal year $1.40FY2026 $11.75FY2026 $7.96FY2026
EPS growth, next FY +18.6%FY2026 +4.9%FY2026 +11.2%FY2026
EPS growth, the year after +7.9% +19.3% +5.3%
Revenue, next fiscal year $3.71BFY2026 $7.27BFY2026 $3.33BFY2026
Revenue growth, next FY +26.0%FY2026 +11.6%FY2026 +8.6%FY2026
Revenue growth, the year after -7.0% +7.0% +6.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBGCCMEVRSK
Held by institutions 84.9% 88.9% 97.6%
Institutions holding 370 1,694 956
Change in shares held, QoQ +3.4% +0.4% -0.4%
Institutions buying 214 824 489
Institutions selling 86 656 350
Buyers to sellers 2.49 1.26 1.40

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BGCCMEVRSK
BGC 1.00 0.27 0.11
CME 0.27 1.00 0.23
VRSK 0.11 0.23 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BGC, CME and VRSK?

Cme (CME) is the largest by market capitalisation: Bgc (BGC) $5.25B, Cme (CME) $114.18B, Verisk Analytics (VRSK) $27.51B.

Which stock is cheaper, BGC, CME and VRSK?

Bgc (BGC) trades on the lowest price-to-earnings ratio (Bgc (BGC) 22.5x, Cme (CME) 25.9x, Verisk Analytics (VRSK) 31.3x). On next year's consensus earnings, Bgc (BGC) is cheapest (Bgc (BGC) 7.9x, Cme (CME) 27.1x, Verisk Analytics (VRSK) 26.1x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Bgc (BGC) grew revenue fastest over the trailing twelve months: Bgc (BGC) +22.9%, Cme (CME) +9.0%, Verisk Analytics (VRSK) +4.9%.

Which company is more profitable?

Cme (CME) has the highest net margin (Bgc (BGC) 6.9%, Cme (CME) 63.3%, Verisk Analytics (VRSK) 27.7%). On return on invested capital, Verisk Analytics (VRSK) leads (Bgc (BGC) 10.6%, Cme (CME) 11.7%, Verisk Analytics (VRSK) 31.9%).

Which stock has performed better?

Over the past year Bgc (BGC) returned the most: Bgc (BGC) +22.4%, Cme (CME) +12.1%, Verisk Analytics (VRSK) -4.5%. Over five years, Bgc (BGC) compounded fastest (Bgc (BGC) +17.3%/yr, Cme (CME) +7.2%/yr, Verisk Analytics (VRSK) -0.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Bgc (BGC) 0.01%, Cme (CME) 0.00%, Verisk Analytics (VRSK) 0.00%. Cme (CME) and Verisk Analytics (VRSK) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Cme (CME) has been the steadiest (Bgc (BGC) 34.5%, Cme (CME) 25.5%, Verisk Analytics (VRSK) 36.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BGC, CME and VRSK?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Bgc (BGC) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.